IL6 and depressive symptom measurement: In addition, high estrogen release during PCOS increases interleukin 4 (IL-4), IL-1, IL-6, and interferon γ (IFN-γ) production (31) and these increases are associated with depression-like symptoms in human and animal studies (57).